Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Blueberries Medical Corp. (C:BBM)

Business Focus: Pharmaceuticals

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for BBM within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Feb 06, 2020 07:45 ET
Blueberries Medical Commissions First Line at Extraction Facility; Secures Supply Agreements with Contract Growers; Further Strengthens Management Team
Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to provide the following update on the Company’s...
Read full article
Dec 16, 2019 17:05 ET
Blueberries Medical Appoints Co-Founder Camilo Villalba as CEO, Exports Expected to Commence in First Half of 2020
Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the "Company" or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Board of Directors has appointed...
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
N/A
--
--
Price to Sales - TTM
--
3.86
9.87
Price to Book - most recent quarter
1.53
2.01
2.10
Price to Cash Flow per share - TTM
--
9.91
10.35
Price to Free Cash Flow per share - TTM
--
13.22
17.60
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Jan 31, 2020104,29379,725
Jan 15, 202024,568-516,730
Dec 31, 2019541,29879,046
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Blueberries Medical Corp. is a Canada-based company, which is a producer of medicinal cannabis and cannabis-derived products. The Company is engaged in the cultivation, production, domestic distribution, and international export of cannabidiol (CBD) and tetrahydrocannabinol (THC)-based medical cannabis.

See business summary

Twitter

Search (past week) for $BBM.CA